| abstract |
The subject of the invention is a pharmaceutical active ingredient consisting exclusively of the combination of (15,3R, 4R, 5R) -3 - {[(2E) -3- (3,4-dihydroxyphenyl)) - 2-propenoyl] oxy} -1,4,5-trihydroxycyclohexanecarboxylic acid and (2S, 3E, 4S) -4- {2- [2- (3,4-Dihydroxyphenyl) ethoxy] -2-oxoethyl} -3-ethylidene Methyl 2- (β-D-glucopyranosyloxy) -3,4-dihydro-2H-pyran-5-carboxylate for use as a medicament or veterinary product, particularly in the prevention and / or treatment of pathological disorders of metabolism carbohydrate and / or lipid. |